BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $587M (95.8% shares, 4.2% debt)

Holdings (30)

— BLUEPRINT MEDICINES CORP 10.2%

Value $60.02M Shares 2,278,459 Est. Cost — Unrealized —

— CHEMOCENTRYX INC 9.2%

Value $54.09M Shares 6,677,722 Est. Cost — Unrealized —

— CTI BIOPHARMA CORP 9.2%

Value $53.87M Shares 43,795,613 Est. Cost — Unrealized —

— CONCERT PHARMACEUTICALS INC 7.2%

Value $42.34M Shares 2,232,014 Est. Cost — Unrealized —

— ONCOTHYREON INC 7.1%

Value $41.73M Shares 18,799,368 Est. Cost — Unrealized —

— VITAE PHARMACEUTICALS INC 6.4%

Value $37.31M Shares 2,061,325 Est. Cost — Unrealized —

IRWD IRONWOOD PHARMACEUTICALS INC 5.8%

Value $34.03M Shares 2,935,975 Est. Cost — Unrealized —

CYTK CYTOKINETICS INC 5.2%

Value $30.55M Shares 2,920,628 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 4.8%

Value $28.2M Shares 6,682,711 Est. Cost — Unrealized —

— FORWARD PHARMA A/S 4.7%

Value $27.38M Shares 1,441,287 Est. Cost — Unrealized —

— ONCOMED PHARMACEUTICALS INC 3.8%

Value $22.35M Shares 991,433 Est. Cost — Unrealized —

— EXELIXIS INC 3.8%

Value $22.19M Shares 18,842,778 Est. Cost — Unrealized —

— LOXO ONCOLOGY INC 3.4%

Value $20.23M Shares 711,067 Est. Cost — Unrealized —

— ARQULE INC 2.5%

Value $14.78M Shares 6,809,843 Est. Cost — Unrealized —

— QLT INC 2.4%

Value $14.27M Shares 5,364,385 Est. Cost — Unrealized —

CTMX CYTOMX THERAPEUTICS INC 2.2%

Value $12.71M Shares 608,848 Est. Cost — Unrealized —

— TOBIRA THERAPEUTICS INC 2.1%

Value $12.6M Shares 1,253,401 Est. Cost — Unrealized —

— FIVE PRIME THERAPEUTICS INC 2.1%

Value $12.45M Shares 300,000 Est. Cost — Unrealized —

— NIVALIS THERAPEUTICS INC 1.6%

Value $9.249M Shares 1,195,013 Est. Cost — Unrealized —

XENE XENON PHARMACEUTICALS INC 1.5%

Value $9.05M Shares 1,125,572 Est. Cost — Unrealized —

— GTX INC DEL 1.3%

Value $7.814M Shares 11,163,136 Est. Cost — Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.7%

Value $4.288M Shares 4,777,381 Est. Cost — Unrealized —

— PAIN THERAPEUTICS INC 0.6%

Value $3.242M Shares 1,852,353 Est. Cost — Unrealized —

— CATALYST BIOSCIENCES INC 0.5%

Value $3.039M Shares 970,948 Est. Cost — Unrealized —

GBIM GLOBEIMMUNE INC 0.4%

Value $2.539M Shares 657,653 Est. Cost — Unrealized —

— ARRAY BIOPHARMA INC 0.4%

Value $2.327M Shares 2,500,000 Est. Cost — Unrealized —

— MAST THERAPEUTICS INC 0.3%

Value $1.554M Shares 3,696,961 Est. Cost — Unrealized —

— CALITHERA BIOSCIENCES INC 0.2%

Value $1.286M Shares 167,900 Est. Cost — Unrealized —

— BIOTA PHARMACEUTIALS INC 0.1%

Value $681K Shares 350,776 Est. Cost — Unrealized —

— NEPHROGENEX INC 0.1%

Value $627K Shares 392,156 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,278,459	$60.02M	10.2%	—	—	COM	09627Y109
—	CHEMOCENTRYX INC	6,677,722	$54.09M	9.2%	—	—	COM	16383L106
—	CTI BIOPHARMA CORP	43,795,613	$53.87M	9.2%	—	—	COM	12648L106
—	CONCERT PHARMACEUTICALS INC	2,232,014	$42.34M	7.2%	—	—	COM	206022105
—	ONCOTHYREON INC	18,799,368	$41.73M	7.1%	—	—	COM	682324108
—	VITAE PHARMACEUTICALS INC	2,061,325	$37.31M	6.4%	—	—	COM	92847N103
IRWD	IRONWOOD PHARMACEUTICALS INC	2,935,975	$34.03M	5.8%	—	—	COM CL A	46333X108
CYTK	CYTOKINETICS INC	2,920,628	$30.55M	5.2%	—	—	COM NEW	23282W605
—	ARRAY BIOPHARMA INC	6,682,711	$28.2M	4.8%	—	—	COM	04269X105
—	FORWARD PHARMA A/S	1,441,287	$27.38M	4.7%	—	—	SPONSORED ADR	34986J105
—	ONCOMED PHARMACEUTICALS INC	991,433	$22.35M	3.8%	—	—	COM	68234X102
—	EXELIXIS INC	18,842,778	$22.19M	3.8%	—	—	NOTE 4.250% 8/1	30161QAC8
—	LOXO ONCOLOGY INC	711,067	$20.23M	3.4%	—	—	COM	548862101
—	ARQULE INC	6,809,843	$14.78M	2.5%	—	—	COM	04269E107
—	QLT INC	5,364,385	$14.27M	2.4%	—	—	COM	746927102
CTMX	CYTOMX THERAPEUTICS INC	608,848	$12.71M	2.2%	—	—	COM	23284F105
—	TOBIRA THERAPEUTICS INC	1,253,401	$12.6M	2.1%	—	—	COM	88883P101
—	FIVE PRIME THERAPEUTICS INC	300,000	$12.45M	2.1%	—	—	COM	33830X104
—	NIVALIS THERAPEUTICS INC	1,195,013	$9.249M	1.6%	—	—	COM	65481J109
XENE	XENON PHARMACEUTICALS INC	1,125,572	$9.05M	1.5%	—	—	COM	98420N105
—	GTX INC DEL	11,163,136	$7.814M	1.3%	—	—	COM	40052B108
—	SUNESIS PHARMACEUTICALS INC	4,777,381	$4.288M	0.7%	—	—	COM NEW	867328601
—	PAIN THERAPEUTICS INC	1,852,353	$3.242M	0.6%	—	—	COM	69562K100
—	CATALYST BIOSCIENCES INC	970,948	$3.039M	0.5%	—	—	COM	14888D109
GBIM	GLOBEIMMUNE INC	657,653	$2.539M	0.4%	—	—	COM	37957B100
—	ARRAY BIOPHARMA INC	2,500,000	$2.327M	0.4%	—	—	NOTE 3.000% 6/0	04269XAA3
—	MAST THERAPEUTICS INC	3,696,961	$1.554M	0.3%	—	—	COM	576314108
—	CALITHERA BIOSCIENCES INC	167,900	$1.286M	0.2%	—	—	COM	13089P101
—	BIOTA PHARMACEUTIALS INC	350,776	$681K	0.1%	—	—	COM	090694100
—	NEPHROGENEX INC	392,156	$627K	0.1%	—	—	COM	640667101